Evidence method
Level · gp.fundamentals.capex_revenue_ratio
6.54% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Dec 31, 2016
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-17-002485General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.47% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
122.22% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
268.59% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
-197.93% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-71.66% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
159.53% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
42.61% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.32%
- Current
- 6.54%
- Delta
- 6.23%
- Previous
- 3.34%
- Current
- 28.47%
- Delta
- 25.13%
- Previous
- 11.50%
- Current
- 122.22%
- Delta
- 110.72%
- Previous
- 56.68%
- Current
- 268.59%
- Delta
- 211.91%
- Previous
- 77.55%
- Current
- -197.93%
- Delta
- -275.48%
- Previous
- 1.48%
- Current
- -71.66%
- Delta
- -73.14%
- Previous
- 7.33%
- Current
- 159.53%
- Delta
- 152.20%
- Previous
- 2.45%
- Current
- 42.61%
- Delta
- 40.16%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_INCREASED →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_DECREASED →Transitioned To · CPIX PROFITABILITY_DECREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.